Notice: Global Information Announces Listing on JASDAQ Standard Market of the Tokyo Stock Exchange

Cover Image
Market Research Report

Implantable Drug Delivery Devices

Published by Global Industry Analysts, Inc. Product code 957345
Published Content info 304 Pages
Delivery time: 1-2 business days
Price
Back to Top
Implantable Drug Delivery Devices
Published: September 1, 2020 Content info: 304 Pages
Description

Global Implantable Drug Delivery Devices Market to Reach $30.2 Billion by 2027

Amid the COVID-19 crisis, the global market for Implantable Drug Delivery Devices estimated at US$20 Billion in the year 2020, is projected to reach a revised size of US$30.2 Billion by 2027, growing at a CAGR of 6.1% over the analysis period 2020-2027. Contraceptive Implants, one of the segments analyzed in the report, is projected to record a 6.3% CAGR and reach US$7.3 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Spinal Implants segment is readjusted to a revised 5.7% CAGR for the next 7-year period.

The U.S. Market is Estimated at $5.9 Billion, While China is Forecast to Grow at 5.7% CAGR

The Implantable Drug Delivery Devices market in the U.S. is estimated at US$5.9 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$5.3 Billion by the year 2027 trailing a CAGR of 5.7% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.8% and 4.9% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 5% CAGR.

Brachytherapy Seeds Segment to Record 6.1% CAGR

In the global Brachytherapy Seeds segment, USA, Canada, Japan, China and Europe will drive the 6.1% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$920.1 Million in the year 2020 will reach a projected size of US$1.4 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$3.5 Billion by the year 2027.We bring years of research experience to this 7th edition of our report. The 304-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others,

  • Abbott Laboratories
  • Allergan PLC
  • Bausch and Lomb, Inc.
  • Bayer AG
  • Boston Scientific Corporation
  • Medtronic PLC
  • Merck & Co., Inc.
  • Teleflex, Inc.
  • Varian Medical Systems, Inc.
Table of Contents
Product Code: MCP16492

TABLE OF CONTENTS

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Global Competitor Market Shares
    • Implantable Drug Delivery Devices Competitor Market Share Scenario Worldwide (in %): 2019 & 2025
    • Impact of Covid-19 and a Looming Global Recession
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Current & Future Analysis for Implantable Drug Delivery Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027
    • TABLE 2: World Historic Review for Implantable Drug Delivery Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
    • TABLE 3: World 15-Year Perspective for Implantable Drug Delivery Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027
    • TABLE 4: World Current & Future Analysis for Contraceptive Implants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027
    • TABLE 5: World Historic Review for Contraceptive Implants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
    • TABLE 6: World 15-Year Perspective for Contraceptive Implants by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 7: World Current & Future Analysis for Spinal Implants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027
    • TABLE 8: World Historic Review for Spinal Implants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
    • TABLE 9: World 15-Year Perspective for Spinal Implants by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 10: World Current & Future Analysis for Brachytherapy Seeds by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027
    • TABLE 11: World Historic Review for Brachytherapy Seeds by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
    • TABLE 12: World 15-Year Perspective for Brachytherapy Seeds by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 13: World Current & Future Analysis for Drug Eluting Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027
    • TABLE 14: World Historic Review for Drug Eluting Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
    • TABLE 15: World 15-Year Perspective for Drug Eluting Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 16: World Current & Future Analysis for Bio-absorbable Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027
    • TABLE 17: World Historic Review for Bio-absorbable Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
    • TABLE 18: World 15-Year Perspective for Bio-absorbable Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 19: World Current & Future Analysis for Intraocular Implants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027
    • TABLE 20: World Historic Review for Intraocular Implants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
    • TABLE 21: World 15-Year Perspective for Intraocular Implants by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 22: World Current & Future Analysis for Infusion Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027
    • TABLE 23: World Historic Review for Infusion Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
    • TABLE 24: World 15-Year Perspective for Infusion Pumps by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 25: World Current & Future Analysis for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027
    • TABLE 26: World Historic Review for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
    • TABLE 27: World 15-Year Perspective for Other Product Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 28: World Current & Future Analysis for Biodegradable by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027
    • TABLE 29: World Historic Review for Biodegradable by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
    • TABLE 30: World 15-Year Perspective for Biodegradable by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 31: World Current & Future Analysis for Non-biodegradable by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027
    • TABLE 32: World Historic Review for Non-biodegradable by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
    • TABLE 33: World 15-Year Perspective for Non-biodegradable by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 34: World Current & Future Analysis for Diffusion by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027
    • TABLE 35: World Historic Review for Diffusion by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
    • TABLE 36: World 15-Year Perspective for Diffusion by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 37: World Current & Future Analysis for Osmotic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027
    • TABLE 38: World Historic Review for Osmotic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
    • TABLE 39: World 15-Year Perspective for Osmotic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 40: World Current & Future Analysis for Magnetic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027
    • TABLE 41: World Historic Review for Magnetic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
    • TABLE 42: World 15-Year Perspective for Magnetic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 43: World Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027
    • TABLE 44: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
    • TABLE 45: World 15-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 46: World Current & Future Analysis for Contraception by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027
    • TABLE 47: World Historic Review for Contraception by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
    • TABLE 48: World 15-Year Perspective for Contraception by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 49: World Current & Future Analysis for Ophthalmology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027
    • TABLE 50: World Historic Review for Ophthalmology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
    • TABLE 51: World 15-Year Perspective for Ophthalmology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 52: World Current & Future Analysis for Cardiovascular by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027
    • TABLE 53: World Historic Review for Cardiovascular by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
    • TABLE 54: World 15-Year Perspective for Cardiovascular by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 55: World Current & Future Analysis for Diabetes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027
    • TABLE 56: World Historic Review for Diabetes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
    • TABLE 57: World 15-Year Perspective for Diabetes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 58: World Current & Future Analysis for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027
    • TABLE 59: World Historic Review for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
    • TABLE 60: World 15-Year Perspective for Oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 61: World Current & Future Analysis for Autoimmune Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027
    • TABLE 62: World Historic Review for Autoimmune Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
    • TABLE 63: World 15-Year Perspective for Autoimmune Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 64: World Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027
    • TABLE 65: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
    • TABLE 66: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

  • GEOGRAPHIC MARKET ANALYSIS
  • UNITED STATES
    • Market Facts & Figures
    • US Implan table Drug Delivery Devices Market Share (in %) by Company: 2019 & 2025
    • Market Analytics
    • TABLE 67: USA Current & Future Analysis for Implantable Drug Delivery Devices by Product Type - Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027
    • TABLE 68: USA Historic Review for Implantable Drug Delivery Devices by Product Type - Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
    • TABLE 69: USA 15-Year Perspective for Implantable Drug Delivery Devices by Product Type - Percentage Breakdown of Value Sales for Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types for the Years 2012, 2020 & 2027
    • TABLE 70: USA Current & Future Analysis for Implantable Drug Delivery Devices by Type - Biodegradable and Non-biodegradable - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027
    • TABLE 71: USA Historic Review for Implantable Drug Delivery Devices by Type - Biodegradable and Non-biodegradable Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
    • TABLE 72: USA 15-Year Perspective for Implantable Drug Delivery Devices by Type - Percentage Breakdown of Value Sales for Biodegradable and Non-biodegradable for the Years 2012, 2020 & 2027
    • TABLE 73: USA Current & Future Analysis for Implantable Drug Delivery Devices by Technology - Diffusion, Osmotic, Magnetic and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027
    • TABLE 74: USA Historic Review for Implantable Drug Delivery Devices by Technology - Diffusion, Osmotic, Magnetic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
    • TABLE 75: USA 15-Year Perspective for Implantable Drug Delivery Devices by Technology - Percentage Breakdown of Value Sales for Diffusion, Osmotic, Magnetic and Other Technologies for the Years 2012, 2020 & 2027
    • TABLE 76: USA Current & Future Analysis for Implantable Drug Delivery Devices by Application - Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027
    • TABLE 77: USA Historic Review for Implantable Drug Delivery Devices by Application - Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
    • TABLE 78: USA 15-Year Perspective for Implantable Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications for the Years 2012, 2020 & 2027
  • CANADA
    • TABLE 79: Canada Current & Future Analysis for Implantable Drug Delivery Devices by Product Type - Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027
    • TABLE 80: Canada Historic Review for Implantable Drug Delivery Devices by Product Type - Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
    • TABLE 81: Canada 15-Year Perspective for Implantable Drug Delivery Devices by Product Type - Percentage Breakdown of Value Sales for Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types for the Years 2012, 2020 & 2027
    • TABLE 82: Canada Current & Future Analysis for Implantable Drug Delivery Devices by Type - Biodegradable and Non-biodegradable - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027
    • TABLE 83: Canada Historic Review for Implantable Drug Delivery Devices by Type - Biodegradable and Non-biodegradable Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
    • TABLE 84: Canada 15-Year Perspective for Implantable Drug Delivery Devices by Type - Percentage Breakdown of Value Sales for Biodegradable and Non-biodegradable for the Years 2012, 2020 & 2027
    • TABLE 85: Canada Current & Future Analysis for Implantable Drug Delivery Devices by Technology - Diffusion, Osmotic, Magnetic and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027
    • TABLE 86: Canada Historic Review for Implantable Drug Delivery Devices by Technology - Diffusion, Osmotic, Magnetic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
    • TABLE 87: Canada 15-Year Perspective for Implantable Drug Delivery Devices by Technology - Percentage Breakdown of Value Sales for Diffusion, Osmotic, Magnetic and Other Technologies for the Years 2012, 2020 & 2027
    • TABLE 88: Canada Current & Future Analysis for Implantable Drug Delivery Devices by Application - Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027
    • TABLE 89: Canada Historic Review for Implantable Drug Delivery Devices by Application - Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
    • TABLE 90: Canada 15-Year Perspective for Implantable Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications for the Years 2012, 2020 & 2027
  • JAPAN
    • TABLE 91: Japan Current & Future Analysis for Implantable Drug Delivery Devices by Product Type - Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027
    • TABLE 92: Japan Historic Review for Implantable Drug Delivery Devices by Product Type - Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
    • TABLE 93: Japan 15-Year Perspective for Implantable Drug Delivery Devices by Product Type - Percentage Breakdown of Value Sales for Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types for the Years 2012, 2020 & 2027
    • TABLE 94: Japan Current & Future Analysis for Implantable Drug Delivery Devices by Type - Biodegradable and Non-biodegradable - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027
    • TABLE 95: Japan Historic Review for Implantable Drug Delivery Devices by Type - Biodegradable and Non-biodegradable Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
    • TABLE 96: Japan 15-Year Perspective for Implantable Drug Delivery Devices by Type - Percentage Breakdown of Value Sales for Biodegradable and Non-biodegradable for the Years 2012, 2020 & 2027
    • TABLE 97: Japan Current & Future Analysis for Implantable Drug Delivery Devices by Technology - Diffusion, Osmotic, Magnetic and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027
    • TABLE 98: Japan Historic Review for Implantable Drug Delivery Devices by Technology - Diffusion, Osmotic, Magnetic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
    • TABLE 99: Japan 15-Year Perspective for Implantable Drug Delivery Devices by Technology - Percentage Breakdown of Value Sales for Diffusion, Osmotic, Magnetic and Other Technologies for the Years 2012, 2020 & 2027
    • TABLE 100: Japan Current & Future Analysis for Implantable Drug Delivery Devices by Application - Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027
    • TABLE 101: Japan Historic Review for Implantable Drug Delivery Devices by Application - Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
    • TABLE 102: Japan 15-Year Perspective for Implantable Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications for the Years 2012, 2020 & 2027
  • CHINA
    • TABLE 103: China Current & Future Analysis for Implantable Drug Delivery Devices by Product Type - Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027
    • TABLE 104: China Historic Review for Implantable Drug Delivery Devices by Product Type - Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
    • TABLE 105: China 15-Year Perspective for Implantable Drug Delivery Devices by Product Type - Percentage Breakdown of Value Sales for Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types for the Years 2012, 2020 & 2027
    • TABLE 106: China Current & Future Analysis for Implantable Drug Delivery Devices by Type - Biodegradable and Non-biodegradable - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027
    • TABLE 107: China Historic Review for Implantable Drug Delivery Devices by Type - Biodegradable and Non-biodegradable Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
    • TABLE 108: China 15-Year Perspective for Implantable Drug Delivery Devices by Type - Percentage Breakdown of Value Sales for Biodegradable and Non-biodegradable for the Years 2012, 2020 & 2027
    • TABLE 109: China Current & Future Analysis for Implantable Drug Delivery Devices by Technology - Diffusion, Osmotic, Magnetic and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027
    • TABLE 110: China Historic Review for Implantable Drug Delivery Devices by Technology - Diffusion, Osmotic, Magnetic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
    • TABLE 111: China 15-Year Perspective for Implantable Drug Delivery Devices by Technology - Percentage Breakdown of Value Sales for Diffusion, Osmotic, Magnetic and Other Technologies for the Years 2012, 2020 & 2027
    • TABLE 112: China Current & Future Analysis for Implantable Drug Delivery Devices by Application - Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027
    • TABLE 113: China Historic Review for Implantable Drug Delivery Devices by Application - Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
    • TABLE 114: China 15-Year Perspective for Implantable Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications for the Years 2012, 2020 & 2027
  • EUROPE
    • Market Facts & Figures
    • European Implan table Drug Delivery Devices Market: Competitor Market Share Scenario (in %) for 2019 & 2025
    • Market Analytics
    • TABLE 115: Europe Current & Future Analysis for Implantable Drug Delivery Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027
    • TABLE 116: Europe Historic Review for Implantable Drug Delivery Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
    • TABLE 117: Europe 15-Year Perspective for Implantable Drug Delivery Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2020 & 2027
    • TABLE 118: Europe Current & Future Analysis for Implantable Drug Delivery Devices by Product Type - Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027
    • TABLE 119: Europe Historic Review for Implantable Drug Delivery Devices by Product Type - Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
    • TABLE 120: Europe 15-Year Perspective for Implantable Drug Delivery Devices by Product Type - Percentage Breakdown of Value Sales for Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types for the Years 2012, 2020 & 2027
    • TABLE 121: Europe Current & Future Analysis for Implantable Drug Delivery Devices by Type - Biodegradable and Non-biodegradable - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027
    • TABLE 122: Europe Historic Review for Implantable Drug Delivery Devices by Type - Biodegradable and Non-biodegradable Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
    • TABLE 123: Europe 15-Year Perspective for Implantable Drug Delivery Devices by Type - Percentage Breakdown of Value Sales for Biodegradable and Non-biodegradable for the Years 2012, 2020 & 2027
    • TABLE 124: Europe Current & Future Analysis for Implantable Drug Delivery Devices by Technology - Diffusion, Osmotic, Magnetic and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027
    • TABLE 125: Europe Historic Review for Implantable Drug Delivery Devices by Technology - Diffusion, Osmotic, Magnetic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
    • TABLE 126: Europe 15-Year Perspective for Implantable Drug Delivery Devices by Technology - Percentage Breakdown of Value Sales for Diffusion, Osmotic, Magnetic and Other Technologies for the Years 2012, 2020 & 2027
    • TABLE 127: Europe Current & Future Analysis for Implantable Drug Delivery Devices by Application - Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027
    • TABLE 128: Europe Historic Review for Implantable Drug Delivery Devices by Application - Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
    • TABLE 129: Europe 15-Year Perspective for Implantable Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications for the Years 2012, 2020 & 2027
  • FRANCE
    • TABLE 130: France Current & Future Analysis for Implantable Drug Delivery Devices by Product Type - Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027
    • TABLE 131: France Historic Review for Implantable Drug Delivery Devices by Product Type - Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
    • TABLE 132: France 15-Year Perspective for Implantable Drug Delivery Devices by Product Type - Percentage Breakdown of Value Sales for Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types for the Years 2012, 2020 & 2027
    • TABLE 133: France Current & Future Analysis for Implantable Drug Delivery Devices by Type - Biodegradable and Non-biodegradable - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027
    • TABLE 134: France Historic Review for Implantable Drug Delivery Devices by Type - Biodegradable and Non-biodegradable Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
    • TABLE 135: France 15-Year Perspective for Implantable Drug Delivery Devices by Type - Percentage Breakdown of Value Sales for Biodegradable and Non-biodegradable for the Years 2012, 2020 & 2027
    • TABLE 136: France Current & Future Analysis for Implantable Drug Delivery Devices by Technology - Diffusion, Osmotic, Magnetic and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027
    • TABLE 137: France Historic Review for Implantable Drug Delivery Devices by Technology - Diffusion, Osmotic, Magnetic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
    • TABLE 138: France 15-Year Perspective for Implantable Drug Delivery Devices by Technology - Percentage Breakdown of Value Sales for Diffusion, Osmotic, Magnetic and Other Technologies for the Years 2012, 2020 & 2027
    • TABLE 139: France Current & Future Analysis for Implantable Drug Delivery Devices by Application - Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027
    • TABLE 140: France Historic Review for Implantable Drug Delivery Devices by Application - Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
    • TABLE 141: France 15-Year Perspective for Implantable Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications for the Years 2012, 2020 & 2027
  • GERMANY
    • TABLE 142: Germany Current & Future Analysis for Implantable Drug Delivery Devices by Product Type - Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027
    • TABLE 143: Germany Historic Review for Implantable Drug Delivery Devices by Product Type - Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
    • TABLE 144: Germany 15-Year Perspective for Implantable Drug Delivery Devices by Product Type - Percentage Breakdown of Value Sales for Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types for the Years 2012, 2020 & 2027
    • TABLE 145: Germany Current & Future Analysis for Implantable Drug Delivery Devices by Type - Biodegradable and Non-biodegradable - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027
    • TABLE 146: Germany Historic Review for Implantable Drug Delivery Devices by Type - Biodegradable and Non-biodegradable Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
    • TABLE 147: Germany 15-Year Perspective for Implantable Drug Delivery Devices by Type - Percentage Breakdown of Value Sales for Biodegradable and Non-biodegradable for the Years 2012, 2020 & 2027
    • TABLE 148: Germany Current & Future Analysis for Implantable Drug Delivery Devices by Technology - Diffusion, Osmotic, Magnetic and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027
    • TABLE 149: Germany Historic Review for Implantable Drug Delivery Devices by Technology - Diffusion, Osmotic, Magnetic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
    • TABLE 150: Germany 15-Year Perspective for Implantable Drug Delivery Devices by Technology - Percentage Breakdown of Value Sales for Diffusion, Osmotic, Magnetic and Other Technologies for the Years 2012, 2020 & 2027
    • TABLE 151: Germany Current & Future Analysis for Implantable Drug Delivery Devices by Application - Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027
    • TABLE 152: Germany Historic Review for Implantable Drug Delivery Devices by Application - Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
    • TABLE 153: Germany 15-Year Perspective for Implantable Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications for the Years 2012, 2020 & 2027
  • ITALY
    • TABLE 154: Italy Current & Future Analysis for Implantable Drug Delivery Devices by Product Type - Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027
    • TABLE 155: Italy Historic Review for Implantable Drug Delivery Devices by Product Type - Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
    • TABLE 156: Italy 15-Year Perspective for Implantable Drug Delivery Devices by Product Type - Percentage Breakdown of Value Sales for Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types for the Years 2012, 2020 & 2027
    • TABLE 157: Italy Current & Future Analysis for Implantable Drug Delivery Devices by Type - Biodegradable and Non-biodegradable - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027
    • TABLE 158: Italy Historic Review for Implantable Drug Delivery Devices by Type - Biodegradable and Non-biodegradable Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
    • TABLE 159: Italy 15-Year Perspective for Implantable Drug Delivery Devices by Type - Percentage Breakdown of Value Sales for Biodegradable and Non-biodegradable for the Years 2012, 2020 & 2027
    • TABLE 160: Italy Current & Future Analysis for Implantable Drug Delivery Devices by Technology - Diffusion, Osmotic, Magnetic and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027
    • TABLE 161: Italy Historic Review for Implantable Drug Delivery Devices by Technology - Diffusion, Osmotic, Magnetic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
    • TABLE 162: Italy 15-Year Perspective for Implantable Drug Delivery Devices by Technology - Percentage Breakdown of Value Sales for Diffusion, Osmotic, Magnetic and Other Technologies for the Years 2012, 2020 & 2027
    • TABLE 163: Italy Current & Future Analysis for Implantable Drug Delivery Devices by Application - Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027
    • TABLE 164: Italy Historic Review for Implantable Drug Delivery Devices by Application - Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
    • TABLE 165: Italy 15-Year Perspective for Implantable Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications for the Years 2012, 2020 & 2027
  • UNITED KINGDOM
    • TABLE 166: UK Current & Future Analysis for Implantable Drug Delivery Devices by Product Type - Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027
    • TABLE 167: UK Historic Review for Implantable Drug Delivery Devices by Product Type - Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
    • TABLE 168: UK 15-Year Perspective for Implantable Drug Delivery Devices by Product Type - Percentage Breakdown of Value Sales for Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types for the Years 2012, 2020 & 2027
    • TABLE 169: UK Current & Future Analysis for Implantable Drug Delivery Devices by Type - Biodegradable and Non-biodegradable - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027
    • TABLE 170: UK Historic Review for Implantable Drug Delivery Devices by Type - Biodegradable and Non-biodegradable Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
    • TABLE 171: UK 15-Year Perspective for Implantable Drug Delivery Devices by Type - Percentage Breakdown of Value Sales for Biodegradable and Non-biodegradable for the Years 2012, 2020 & 2027
    • TABLE 172: UK Current & Future Analysis for Implantable Drug Delivery Devices by Technology - Diffusion, Osmotic, Magnetic and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027
    • TABLE 173: UK Historic Review for Implantable Drug Delivery Devices by Technology - Diffusion, Osmotic, Magnetic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
    • TABLE 174: UK 15-Year Perspective for Implantable Drug Delivery Devices by Technology - Percentage Breakdown of Value Sales for Diffusion, Osmotic, Magnetic and Other Technologies for the Years 2012, 2020 & 2027
    • TABLE 175: UK Current & Future Analysis for Implantable Drug Delivery Devices by Application - Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027
    • TABLE 176: UK Historic Review for Implantable Drug Delivery Devices by Application - Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
    • TABLE 177: UK 15-Year Perspective for Implantable Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications for the Years 2012, 2020 & 2027
  • REST OF EUROPE
    • TABLE 178: Rest of Europe Current & Future Analysis for Implantable Drug Delivery Devices by Product Type - Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027
    • TABLE 179: Rest of Europe Historic Review for Implantable Drug Delivery Devices by Product Type - Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
    • TABLE 180: Rest of Europe 15-Year Perspective for Implantable Drug Delivery Devices by Product Type - Percentage Breakdown of Value Sales for Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types for the Years 2012, 2020 & 2027
    • TABLE 181: Rest of Europe Current & Future Analysis for Implantable Drug Delivery Devices by Type - Biodegradable and Non-biodegradable - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027
    • TABLE 182: Rest of Europe Historic Review for Implantable Drug Delivery Devices by Type - Biodegradable and Non-biodegradable Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
    • TABLE 183: Rest of Europe 15-Year Perspective for Implantable Drug Delivery Devices by Type - Percentage Breakdown of Value Sales for Biodegradable and Non-biodegradable for the Years 2012, 2020 & 2027
    • TABLE 184: Rest of Europe Current & Future Analysis for Implantable Drug Delivery Devices by Technology - Diffusion, Osmotic, Magnetic and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027
    • TABLE 185: Rest of Europe Historic Review for Implantable Drug Delivery Devices by Technology - Diffusion, Osmotic, Magnetic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
    • TABLE 186: Rest of Europe 15-Year Perspective for Implantable Drug Delivery Devices by Technology - Percentage Breakdown of Value Sales for Diffusion, Osmotic, Magnetic and Other Technologies for the Years 2012, 2020 & 2027
    • TABLE 187: Rest of Europe Current & Future Analysis for Implantable Drug Delivery Devices by Application - Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027
    • TABLE 188: Rest of Europe Historic Review for Implantable Drug Delivery Devices by Application - Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
    • TABLE 189: Rest of Europe 15-Year Perspective for Implantable Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications for the Years 2012, 2020 & 2027
  • ASIA-PACIFIC
    • TABLE 190: Asia-Pacific Current & Future Analysis for Implantable Drug Delivery Devices by Product Type - Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027
    • TABLE 191: Asia-Pacific Historic Review for Implantable Drug Delivery Devices by Product Type - Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
    • TABLE 192: Asia-Pacific 15-Year Perspective for Implantable Drug Delivery Devices by Product Type - Percentage Breakdown of Value Sales for Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types for the Years 2012, 2020 & 2027
    • TABLE 193: Asia-Pacific Current & Future Analysis for Implantable Drug Delivery Devices by Type - Biodegradable and Non-biodegradable - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027
    • TABLE 194: Asia-Pacific Historic Review for Implantable Drug Delivery Devices by Type - Biodegradable and Non-biodegradable Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
    • TABLE 195: Asia-Pacific 15-Year Perspective for Implantable Drug Delivery Devices by Type - Percentage Breakdown of Value Sales for Biodegradable and Non-biodegradable for the Years 2012, 2020 & 2027
    • TABLE 196: Asia-Pacific Current & Future Analysis for Implantable Drug Delivery Devices by Technology - Diffusion, Osmotic, Magnetic and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027
    • TABLE 197: Asia-Pacific Historic Review for Implantable Drug Delivery Devices by Technology - Diffusion, Osmotic, Magnetic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
    • TABLE 198: Asia-Pacific 15-Year Perspective for Implantable Drug Delivery Devices by Technology - Percentage Breakdown of Value Sales for Diffusion, Osmotic, Magnetic and Other Technologies for the Years 2012, 2020 & 2027
    • TABLE 199: Asia-Pacific Current & Future Analysis for Implantable Drug Delivery Devices by Application - Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027
    • TABLE 200: Asia-Pacific Historic Review for Implantable Drug Delivery Devices by Application - Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
    • TABLE 201: Asia-Pacific 15-Year Perspective for Implantable Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications for the Years 2012, 2020 & 2027
  • REST OF WORLD
    • TABLE 202: Rest of World Current & Future Analysis for Implantable Drug Delivery Devices by Product Type - Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027
    • TABLE 203: Rest of World Historic Review for Implantable Drug Delivery Devices by Product Type - Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
    • TABLE 204: Rest of World 15-Year Perspective for Implantable Drug Delivery Devices by Product Type - Percentage Breakdown of Value Sales for Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bio-absorbable Stents, Intraocular Implants, Infusion Pumps and Other Product Types for the Years 2012, 2020 & 2027
    • TABLE 205: Rest of World Current & Future Analysis for Implantable Drug Delivery Devices by Type - Biodegradable and Non-biodegradable - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027
    • TABLE 206: Rest of World Historic Review for Implantable Drug Delivery Devices by Type - Biodegradable and Non-biodegradable Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
    • TABLE 207: Rest of World 15-Year Perspective for Implantable Drug Delivery Devices by Type - Percentage Breakdown of Value Sales for Biodegradable and Non-biodegradable for the Years 2012, 2020 & 2027
    • TABLE 208: Rest of World Current & Future Analysis for Implantable Drug Delivery Devices by Technology - Diffusion, Osmotic, Magnetic and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027
    • TABLE 209: Rest of World Historic Review for Implantable Drug Delivery Devices by Technology - Diffusion, Osmotic, Magnetic and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
    • TABLE 210: Rest of World 15-Year Perspective for Implantable Drug Delivery Devices by Technology - Percentage Breakdown of Value Sales for Diffusion, Osmotic, Magnetic and Other Technologies for the Years 2012, 2020 & 2027
    • TABLE 211: Rest of World Current & Future Analysis for Implantable Drug Delivery Devices by Application - Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027
    • TABLE 212: Rest of World Historic Review for Implantable Drug Delivery Devices by Application - Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
    • TABLE 213: Rest of World 15-Year Perspective for Implantable Drug Delivery Devices by Application - Percentage Breakdown of Value Sales for Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases and Other Applications for the Years 2012, 2020 & 2027

IV. COMPETITION

  • Total Companies Profiled: 46
Back to Top